Skip to main content
. 2021 Jan 13;16(1):e0245160. doi: 10.1371/journal.pone.0245160

Table 2. Clinical details, MIC distribution, and mutation status of the azole resistant isolates.

NCCPF ID GenBank accession number Source of isolates Flu MIC (mg/L) Vori MIC (mg/L) Itra MIC (mg/L) Posa MICs (mg/L) ERG11 mutations Amino acid alterations
420189 MW015956 Blood 128 4 0.5 0.5 A395T & C461T Y132F & S154F
420227 MW015957 Pus 128 0.5 0.25 0.5 A395T & C461T Y132F & S154F
420232 MW015958 Blood 32 0.5 0.5 0.5 A395T & C461T Y132F & S154F
420233 MW015959 Blood 32 1 0.25 0.25 A395T & C461T Y132F & S154F
420234 MW015960 Blood 64 1 0.25 0.25 A395T & C461T Y132F & S154F
420235 MW015961 Blood 32 0.5 0.25 0.25 A395T & C461T Y132F & S154F
420236 MW015962 Blood 32 0.5 0.25 0.25 A395T & C461T Y132F & S154F
420237 MW015963 Blood 64 1 0.5 0.5 A395T & C461T Y132F & S154F
420238 MW015964 Ascitic fluid 256 16 16 2 A395T & C461T Y132F & S154F
420239 MW015965 Blood 256 16 16 0.5 A395T & C461T Y132F & S154F
420245 MW015966 Blood 128 4 1 0.5 A395T & C461T Y132F & S154F
420247 MW015967 Wound slough 128 4 2 0.25 A395T & C461T Y132F & S154F

Flu: Fluconazole; Vori: Voriconazole; Itra: Itraconazole; Posa: Posaconazole; Y: Tyrosine; F: Phenylalanine; S: Serine